Company: JUPGF
Filing Date: 2025-07-01
Form Type: DRS/A
Source: 0001641172-25-017223
Chunk: 141

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-07-01
Form: DRS/A
Chunk 141
---
 by the stockholders. For example, the Board of Directors is authorized to issue preferred stock that would have the right to
vote, separately or with any other stockholder of preferred stock, on any proposed amendment to our certificate of incorporation, or on
any other proposed corporate action, including business combinations and other transactions.

We will not offer preferred stock unless the offering
is approved by a majority of our independent directors. The independent directors will have access, at our expense, to our counsel or
independent counsel.

Options and Warrants

As of the date of this prospectus, options to purchase up to 236,667 shares of our common stock were issued and outstanding, with a weighted-average time of exercise of 1.85 years, and a weighted-average exercise price of $0.93.

As of the date of this prospectus, the Company does not have any outstanding warrants to purchase shares of our common stock.

Equity Awards

During the year ended December 31, 2024, the
Company granted Mr. Fogassa as contractual compensation options to purchase an aggregate of 210,000 shares of its common stock. The options issued in 2024 were valued at $41,938 in total.
The options were valued using the Black-Scholes option pricing model with the following average assumptions: our stock price on date
of grant $0.74 to $1.00, a strike price of $0.01 to $1.00, illiquidity discount of 75%, expected dividend yield of 0%, annualized volatility
of 241% to 312%, risk-free interest rate of 3.88% to 4.64%, and an expected term of five to ten years.

During the year ended December 31, 2023, the Company
granted Marc Fogassa as contractual compensation options to purchase an aggregate of 420,000 shares of its common stock. Such awards corresponded
to the period between January 1, 2023, to December 31, 2023. The options issued in 2023 were valued at $115,038 in total. The options
were valued using the Black-Scholes option pricing model with the following average assumptions: our stock price on date of grant $0.65
to $2.10, a strike price of $0.01 to $1.00, illiquidity discount of 75%, expected dividend yield of 0%, annualized volatility of 268%
to 364%,